Shojaei: The effectiveness of nano‐curcumin on patients with <scp>COVID</scp> ‐19: A systematic review of clinical trials

The effectiveness of nano‐curcumin on patients with COVID ‐19: A systematic review of clinical trials

Shojaei et al., Phytotherapy Research, doi:10.1002/ptr.7778 (meta analysis)

Shojaei et al., The effectiveness of nano‐curcumin on patients with COVID ‐19: A systematic review of clinical.., Phytotherapy Research, doi:10.1002/ptr.7778 (meta analysis)

Feb 2023 Source PDF

Twitter
Facebook

All Studies Meta

Meta analysis of 8 nano-curcumin COVID-19 studies, showing significantly lower mortality and shorter hospitalization with treatment.

Currently there are 24 curcumin studies and meta analysis shows:

Outcome	Improvement
Mortality	63% lower [35‑79%]
Ventilation	77% lower [-6‑95%]
ICU admission	67% lower [-211‑96%]
Hospitalization	25% lower [15‑33%]

Important missing comments or errors? Let us know.

Shojaei et al., 17 Feb 2023, peer-reviewed, 7 authors.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Curcumin All

Download Image

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit